← back to search

Anja Lachenmayer

University Hospital of Bern ·
Area of research
Hepatology · Pathology and Forensic Medicine
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Parasitic infections in humans and animals, Cholangiocarcinoma and Gallbladder Cancer Studies, and Parasitic Infections and Diagnostics.
h-index
29
citations
4,198
works
101
NIH funding
primary concept
email

Recent publications

International multisociety Delphi consensus for liver tumour thermal ablation: margin assessment
The Lancet Oncology 2026cited by 2position: middledoi
Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma
Journal of Hepatology 2024cited by 33position: middledoi
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Journal of Hepatology 2021cited by 227position: middledoi
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
JHEP Reports 2021cited by 67position: middledoi
Corrigendum to ‘Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis’ [J Hepatol 75 (2021) 865–878]
Journal of Hepatology 2021cited by 13position: middledoi
Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival
Surgery 2020cited by 59position: middledoi
Minimal-Invasive Versus Open Hepatectomy for Colorectal Liver Metastases: Bicentric Analysis of Postoperative Outcomes and Long-Term Survival Using Propensity Score Matching Analysis
Journal of Clinical Medicine 2020cited by 19position: middledoi
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Nature Reviews Clinical Oncology 2015cited by 638position: middledoi
UHRF1 Overexpression Drives DNA Hypomethylation and Hepatocellular Carcinoma
Cancer Cell 2014cited by 322position: middledoi
Genome-Wide Methylation Analysis and Epigenetic Unmasking Identify Tumor Suppressor Genes in Hepatocellular Carcinoma
Gastroenterology 2013cited by 215position: middledoi
Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib
Clinical Cancer Research 2012cited by 299position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Josep M. Llovet · Mayo Clinic in Florida4 papers (2012–2015)Yujin Hoshida · WinnMed3 papers (2012–2014)Augusto Villanueva · NYU Langone Health3 papers (2012–2015)Johann Pratschke · Johnson & Johnson (United States)2 papers (2020–2020)Swan N. Thung · Mount Sinai Health System2 papers (2012–2014)Daniel Candinas · Tracer Technologies (United States)2 papers (2020–2020)Andréas Andreou · St George’s University Hospitals NHS Foundation Trust2 papers (2020–2020)Kate Revill · Emory University2 papers (2013–2014)Kensuke Kojima · NHO Kinki Chuo Chest Medical Center2 papers (2013–2014)Clara Alsinet · AstraZeneca (Spain)2 papers (2012–2014)Sebastian Knitter · Humboldt-Universität zu Berlin2 papers (2020–2020)Moritz Schmelzle · Medizinische Hochschule Hannover2 papers (2020–2020)Vanessa Banz · University Hospital of Zurich2 papers (2020–2020)Wenzel Schöning · Humboldt-Universität zu Berlin2 papers (2020–2020)Guido Beldi · Universitätsklinik für Neurologie2 papers (2020–2020) · 2 papers (2020–2020)Yelena Chernyavskaya · University of Kentucky1 papers (2014–2014)Ravi Sachidanandam · New York Medical College1 papers (2014–2014)Andrew Harrington · Indiana University1 papers (2013–2013)Jinyu Li · New York University1 papers (2013–2013)